Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial

Research output: Contribution to journalJournal articleResearchpeer-review

  • Jensen, Jens Ulrik
  • Lars Hein
  • Bettina Lundgren
  • Bestle, Morten Heiberg
  • Thomas T Mohr
  • Andersen, Mads Hald
  • Klaus J Thornberg
  • Jesper Løken
  • Morten Steensen
  • Zoe Fox
  • Hamid Tousi
  • Peter Søe-Jensen
  • Anne Ø Lauritsen
  • Ditte Strange
  • Pernille L Petersen
  • Nanna Reiter
  • Søren Hestad
  • Katrin Thormar
  • Paul Fjeldborg
  • Kim M Larsen
  • Niels E Drenck
  • Christian Ostergaard
  • Jesper Kjær
  • Jesper Grarup
  • Lundgren, Jens
  • Procalcitonin And Survival Study (PASS) Group
For patients in intensive care units, sepsis is a common and potentially deadly complication and prompt initiation of appropriate antimicrobial therapy improves prognosis. The objective of this trial was to determine whether a strategy of antimicrobial spectrum escalation, guided by daily measurements of the biomarker procalcitonin, could reduce the time to appropriate therapy, thus improving survival.
Original languageEnglish
JournalCritical Care Medicine
Volume39
Issue number9
Pages (from-to)2048-58
Number of pages11
ISSN0090-3493
DOIs
Publication statusPublished - 1 Sep 2011

    Research areas

  • Aged, Algorithms, Anti-Bacterial Agents, Biological Markers, Calcitonin, Female, Hospital Mortality, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Protein Precursors, Respiration, Artificial, Sepsis, Time Factors

ID: 35412675